Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

Selecting clinically relevant populations for reference intervals

Robert F. Ritchie / Glenn Palomaki

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 42, Issue 7, Pages 702–709, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2004.120, June 2005

Publication History

Published Online:
2005-06-01

Abstract

The selection of individuals to represent a group for any purpose can commit the effort to success or failure from the very outset. The description of this group must reflect what is, in reality, the purpose for which the group is being studied. Considering that reference intervals are designed to assist clinicians during diagnostic triage, criteria must reflect the nature of the subjects entering the system for care. The majority of people seeking care have non-life-threatening, yet troublesome complaints. In other words, persons who are in a reasonable state of health and who are not suffering from significant illness. Therefore the relevant cohort should fit this description, not individuals who lack any clinical or laboratory issues. Our focus is to employ reference intervals to exclude disease and not to define normality. Normality in the eyes of statisticians is quite different from the word as viewed by clinical staff, yet the term is used interchangeably without concern for its ultimate use. As a result medicine today stumbles over this issue at every turn. Scientists and artists do not speak the same language.

Compounding this awkward situation has been the conviction that by increasing laboratory precision and accuracy, the utility of laboratory data, reference intervals in particular, will improve clinical understanding. This has, after many years, not proven to be the case. What has become very evident, however, is that unsustainably large sums of money are being devoted to improving laboratory performance. To what end, when we are unable to grasp the significance of what is available now including published reference intervals for common test values?

A realistic perspective on the value of prevailing laboratory performance, as illustrated by reference intervals, must be adopted. The obligation of laboratories, its regulators and professional groups is to create a sustainable mechanism to provide clinically usable information, in a timely and affordable manner, to our population and to those legions of less fortunate humans.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Petra A.T. Araújo, Dylan Thomas, Tara Sadeghieh, Victoria Bevilacqua, Man Khun Chan, Yunqi Chen, Edward Randell, and Khosrow Adeli
Clinical Biochemistry, 2015
[2]
Hallvard Lilleng, Stein Harald Johnsen, Tom Wilsgaard, and Svein Ivar Bekkelund
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 5
[3]
Samuel Lurie, Einam Rahamim, Irena Piper, Abraham Golan, and Oscar Sadan
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2008, Volume 136, Number 1, Page 16
[4]
Craig A. Downs, Cheryl M. Woodley, Robert H. Richmond, Lynda L. Lanning, and Richard Owen
Marine Pollution Bulletin, 2005, Volume 51, Number 5-7, Page 486
[5]
Lone G. M. Jørgensen, Per Hyltoft Petersen, Lene Heickendorff, Holger Jon Møller, Jørn Hendel, Cramer Christensen, Anita Schmitz, Birgitte Reinholdt, Erik D. Lund, Niels J. Christensen, Erik Kjærsgaard Hansen, Jens Hastrup, Hanne Skjødt, Ebbe Wendel Eriksen, and Ivan Brandslund
Clinical Chemical Laboratory Medicine, 2005, Volume 43, Number 12
[6]
Rebecca S. Nicolich, Monica C. Padilha, and Francisco R. de Aquino Neto
Drug Testing and Analysis, 2010, Volume 2, Number 11-12, Page 599
[7]
Mark M. Kushnir, Alan L. Rockwood, and Jonas Bergquist
Mass Spectrometry Reviews, 2010, Volume 29, Number 3, Page 480
[8]
Saud Iqbal, Majeed R. Al-Ani, Jamilah A. Al-Zadjali, Zahra Z. Al-Abri, and Buthaina S. Al- Belush
Journal of Medical Sciences(Faisalabad), 2009, Volume 9, Number 2, Page 81
[9]
Javier Romeo, Julia W��rnberg, Sonia G��mez-Mart��nez, Ligia E. D��az, Luis A. Moreno, Manuel J. Castillo, Carlos Redondo, Juan C. Baraza, Ricardo Sola, Salvador Zamora, and Ascensi��n Marcos
European Journal of Haematology, 2009, Volume 83, Number 6, Page 586
[11]
Llorenç Quintó, John J. Aponte, Jahit Sacarlal, Mateu Espasa, Pedro Aide, Inacio Mandomando, Caterina Guinovart, Eusebio Macete, Margarita M. Navia, Ricardo Thompson, Clara Menéndez, and Pedro L. Alonso
Tropical Medicine and International Health, 2006, Volume 11, Number 11, Page 1741

Comments (0)

Please log in or register to comment.